REDWOOD CITY, Calif. — Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it has appointed Rachel Haurwitz, Ph.D. to serve on its Board of Directors, effective November 8, 2021. Dr. Haurwitz is currently CEO of Caribou Biosciences, Inc. a clinical-stage biopharmaceutical company developing genome-edited off-the-shelf immune […]

BERWYN, Pa. — AMETEK, Inc. (NYSE: AME) today named Emanuela Speranza as Chief Commercial Officer and a member of the company’s Executive Office, effective January 1, 2022. In this newly created role, Ms. Speranza will work with AMETEK businesses to drive accelerated organic sales growth by leading company-wide commercial excellence initiatives and managing global marketing communications. She […]

BERWYN, Pa. — AMETEK, Inc. (NYSE: AME) today announced that its Board of Directors has elected Kevin Coleman as Treasurer. In addition to taking on this role, Mr. Coleman will continue to serve as Vice President, Investor Relations. “We are pleased that Kevin will be filling this important leadership role,” said David A. Zapico, AMETEK Chairman […]

SAN DIEGO — Bionano Genomics, Inc. (BNGO), developer of the Saphyr® system that uses optical genome mapping (OGM) for the detection and analysis of structural variants (SVs), today announced that two former Illumina executives, Stephanie Hoyle and Alex Helm, have joined the Company as vice presidents of Corporate Marketing and Strategic Product Marketing, respectively. Together, they bring 22 years […]

CHELMSFORD, Mass. — Brooks Automation, Inc. (Nasdaq: BRKS) today announced that Frank Casal has been elected to its Board of Directors. Mr. Casal most recently served as Vice Chair, Audit for KPMG, LLP, the U.S. member firm of KPMG International (KPMGI). He joins the Brooks Board and Audit Committee, bringing deep business acumen, leadership experience and expertise. “We […]

CAMBRIDGE, Mass. — Ultivue announces the addition of Steve Pemberton in the role of SVP Commercial Development, as the company adds to its growing executive team. Steve is a seasoned commercial executive with 25 years of experience building and leading high performing sales and marketing teams. Steve was most recently the Vice President, Commercial Development […]

Former product innovator at BGI, Illumina, and Pacific Biosciences will spearhead technological development of breakthrough Molecular Cartography™ system MONHEIM AM RHEIN, Germany —  Resolve Biosciences, the pioneer in Molecular Cartography™, today announced the appointment of Frank Zhong, PhD, as Chief Technology Officer. In this role, Zhong will report to Co-founder and CEO Jason T. Gammack […]

Arul Chinnaiyan and Sten Linnarsson to bolster Rebus expertise and scientific direction SANTA CLARA, Calif. —  Rebus Biosystems Inc., (“Rebus Bio”, “Rebus”), an Illumina Ventures-backed life science technology company creating revolutionary tools to advance spatial omics research, today announced that Drs. Arul Chinnaiyan, MD, PhD, and Sten Linnarsson, PhD, have been appointed to the Company’s […]

SANTA CLARA, Calif. — Agilent Technologies, Inc. (NYSE: A) today announced that John Palma has joined the company as vice president, Medical Affairs. In this role, he will build and lead the companywide Global Medical Affairs organization. Palma has more than 26 years of experience in the development, management, and delivery of complex diagnostics and […]

Leaders in tech, biotech, and synthetic biology join to advance first commercial molecular electronics chip SAN DIEGO, Calif. — Roswell Biotechnologies, Inc., the molecular electronics company, announced today the formation of its Scientific Advisory Board (SAB). Comprised of industry and academic leaders in science and technology, the new SAB will be instrumental in the final […]